(Q30828846)

26 June 2017

1 reference

title

Guidelines for management of Bowen's disease: 2006 update (English)

1 reference

26 June 2017

1 reference

N H Cox

1

1 reference

26 June 2017

D J Eedy

series ordinal

2

1 reference

26 June 2017

C A Morton

series ordinal

3

1 reference

26 June 2017

Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists

series ordinal

4

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

British Journal of Dermatology

26 June 2017

1 reference

26 June 2017

156

1 reference

26 June 2017

11-21

1 reference

26 June 2017

1

1 reference

Guidelines for management of Bowen's disease. British Association of Dermatologists

26 June 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Thirteen-year retrospective study of Bowen's disease in Northern Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Body site distribution of Bowen's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Summary of inaugural meeting of the Skin Care in Organ Recipients Group, UK, held at the Royal Society of Medicine, 7 October 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Human papillomavirus and extragenital in situ carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Human papillomavirus infection in actinic keratosis and bowen’s disease: comparative study with expression of cell-cycle regulatory proteins p21waf1/cip1, p53, pcna, ki-67, and bcl-2 in positive and negative lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Perianal Bowen's disease: associated tumors, human papillomavirus, surgery, and other controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Perianal Bowen's disease: a clinicopathologic study of 47 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Erbium:YAG laser pretreatment accelerates the response of Bowen's disease treated by topical 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Topical treatment of Bowen's disease with 5-Fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Imiquimod 5% cream in the treatment of Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Treatment of large facial Bowen's disease: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Treatment of Bowen's disease and erythroplasia of Queyrat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Comparison of cryotherapy with curettage in the treatment of Bowen's disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin. Series of 57 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Cutaneous squamous carcinoma in situ (Bowen's disease): treatment with Mohs micrographic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Photodynamic therapy for Bowen's disease (squamous cell carcinoma in situ) of the digit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Radiation therapy for Bowen's disease: lessons for lesions of the lower extremity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Treatment of Bowen's disease with a specially designed radioactive skin patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Treatment of Bowen's disease of the digit with carbon dioxide laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Bowen's disease of the distal digit. Outcome of treatment with carbon dioxide laser vaporization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

Treating Bowen's disease: a cost-minimization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07610.X

10.1111/J.1365-2133.2006.07610.X

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference